Urticaria is a common dermatological condition characterized by the sudden appearance of transient, pruritic wheals with or without angioedema. It affects approximately 15–25% of individuals at least once during their lifetime and is commonly triggered by infections, foods, medications, insect bites, or environmental factors. Acute urticaria lasts for less than six weeks and is primarily mediated by mast cell degranulation with subsequent histamine release. Although most episodes are self-limiting, severe cases may progress to angioedema or anaphylaxis, requiring prompt recognition and treatment. Early diagnosis based on clinical history and exclusion of differential diagnoses facilitates appropriate management and prevents recurrence.
We report the case of a 28-year-old woman who presented with sudden-onset intensely itchy erythematous wheals over the trunk and extremities accompanied by mild swelling of the lips after consuming shellfish. Clinical examination and laboratory investigations supported the diagnosis of acute food-induced urticaria without systemic anaphylaxis. The patient was successfully treated with oral second-generation antihistamines, a short course of corticosteroids, avoidance of the offending allergen, and patient education. Complete resolution of symptoms occurred within five days without recurrence during follow-up. This case highlights the importance of early recognition, identification of triggering factors, and evidence-based treatment in achieving rapid symptom control.
Urticaria is a vascular reaction of the skin characterized by transient wheals resulting from localized dermal edema caused by mast cell activation and release of histamine, leukotrienes, prostaglandins, and other inflammatory mediators. Individual wheals typically persist for less than 24 hours and resolve without residual pigmentation or scarring. The condition may occur alone or in association with angioedema involving the deeper dermis and subcutaneous tissues.
Acute urticaria accounts for the majority of urticaria cases and usually resolves within six weeks. Common precipitating factors include food allergens such as shellfish, peanuts, eggs, and milk; medications including antibiotics and non-steroidal anti-inflammatory drugs; viral infections; insect stings; and physical stimuli.
Clinical manifestations include:
Although diagnosis is primarily clinical, careful evaluation is necessary to exclude anaphylaxis, urticarial vasculitis, autoimmune disorders, and other dermatological conditions. Second-generation H1-antihistamines remain the first-line therapy, while systemic corticosteroids are reserved for severe acute episodes.
Patient History
A 28-year-old woman presented to the dermatology outpatient department with complaints of sudden-onset itchy skin rashes over the arms, trunk, neck, and thighs for six hours. The lesions appeared approximately one hour after consuming shellfish at a restaurant. She also noticed mild swelling of her lips but denied difficulty breathing, wheezing, throat tightness, dizziness, or loss of consciousness.
She had no previous history of chronic urticaria, asthma, eczema, autoimmune disease, or recent infections. There was no history of new medications or insect bites. Family history was unremarkable for allergic disorders.
The patient was alert and hemodynamically stable.
Vital signs
Dermatological examination




Systemic examination
The following conditions were considered:
Routine laboratory investigations were performed to exclude systemic illness.
Laboratory Evaluation
Serum tryptase estimation was not performed because the patient showed no evidence of systemic anaphylaxis.
Based on the temporal relationship between shellfish ingestion and symptom onset, allergy testing was deferred until complete symptom resolution.
Considering the clinical presentation, physical examination, and history of recent shellfish consumption, a diagnosis of acute food-induced urticaria with mild angioedema was established.
The patient was immediately advised to avoid further exposure to shellfish.
Treatment included:
The patient was observed in the emergency department for four hours because of mild lip swelling. Throughout observation, she remained hemodynamically stable without progression to respiratory compromise or hypotension.
Since there were no features of anaphylaxis, intramuscular adrenaline was not required.
The itching reduced significantly within 24 hours, and the wheals gradually disappeared over the next three days.
Three Days
One Week
One Month
The patient remained symptom-free and successfully avoided shellfish. She was counseled regarding recognition of severe allergic reactions and advised to undergo formal allergy evaluation for confirmation of the suspected food trigger.
Acute urticaria is among the most frequent allergic skin disorders encountered in clinical practice. The disease results from activation of dermal mast cells and basophils, leading to the release of histamine and other inflammatory mediators that increase vascular permeability and produce characteristic wheals and pruritus.
Food allergy is an important cause of acute urticaria in adults, with shellfish being one of the most common triggers worldwide. Symptoms usually develop within minutes to a few hours after exposure. Diagnosis relies heavily on obtaining a detailed clinical history because routine laboratory investigations are frequently normal.
The principal objective of treatment is rapid symptom control while preventing progression to life-threatening anaphylaxis. International guidelines recommend second-generation H1-antihistamines as first-line therapy due to their excellent efficacy and favorable safety profile. Short courses of systemic corticosteroids may be considered in severe acute episodes associated with extensive skin involvement or angioedema but should not be used for prolonged periods because of potential adverse effects.
Recognition of warning signs such as hypotension, bronchospasm, laryngeal edema, or persistent gastrointestinal symptoms is essential, as these indicate evolving anaphylaxis requiring immediate intramuscular adrenaline. Fortunately, the present patient exhibited only mild angioedema without systemic involvement and responded promptly to conservative therapy.
Patient education remains a cornerstone of management. Identification and avoidance of precipitating allergens substantially reduce recurrence. Individuals with confirmed food allergies should be informed about careful food labeling, cross-contamination risks, and the importance of seeking urgent medical care if respiratory or cardiovascular symptoms develop following future exposures.
Acute urticaria generally has an excellent prognosis, with most patients achieving complete recovery within days to weeks following elimination of the offending trigger and appropriate antihistamine therapy. Recurrence can usually be prevented through allergen avoidance and patient education. Progression to chronic urticaria is uncommon after isolated food-induced episodes. Long-term outcomes are favorable when early recognition and evidence-based treatment are instituted.
Conclusion
Acute food-induced urticaria is a common hypersensitivity reaction that can cause considerable patient distress but usually responds rapidly to timely treatment. Careful clinical history, recognition of potential triggers, and exclusion of anaphylaxis are fundamental to diagnosis. Second-generation antihistamines remain the cornerstone of therapy, while short courses of corticosteroids may be beneficial in selected severe cases. Early intervention, allergen avoidance, and patient counseling are essential to minimize recurrence and improve quality of life.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation